Shree Ganesh Bio-Tech (India) Limited / Fundamentals
Income statement
- Net revenue
€2.26M - Cost of goods sold
€2.23M - Gross profit
€28.98K - SG&A expenses
€9.62K - R&D expenses
€0.00 - EBITDA
€134.38K - D&A
€81.34 - EBIT
-€103.90K - Interest expenses
€0.00 - EBT
€38.15K - Tax expenses
€10.70K - Net income
€27.45K
Cash flow statement
- Net deferred tax
€0.00 - Non-cash items
-€38.15K - Changes in working capital
€0.00 - Operating cash flow
€0.00 - Capex
€0.00 - Other investing cash flow
€0.00 - Net investing cash flow
€0.00 - Total cash dividends paid
€0.00 - Issuance of common stock
€0.00 - Debt repayment
€0.00 - Other financing cash flow
€0.00 - Net financing cash flow
€0.00 - Foreign exchange effects
€0.00 - Net change in cash
€0.00 - Cash at end of period
€0.00 - Free cash flow
€0.00
Balance sheet
- Cash and cash equivalents
€1.29K - Cash and short-term investments
€951.92K - Total receivables
€0.00 - Inventory
€284.93K - Other current assets
€0.00 - Total current assets
€1.24M - Property, plant & equipment
€187.33 - Goodwill
€0.00 - Intangible assets
€0.00 - Long-term investments
€5.02M - Other non-current assets
€5.02M - Total non-current assets
€5.02M - Total assets
€6.26M - Accounts payable
€0.00 - Short-term debt
€0.00 - Other current liabilities
€22.84K - Total current liabilities
€22.84K - Long-term debt
€0.00 - Deferred tax liabilities
€0.00 - Other non-current liabilities
€0.00 - Total non-current liabilities
€0.00 - Total liabilities
€22.84K - Common stock
€3.93M - Retained earnings
€0.00 - Other equity
€0.00 - Total equity
€6.24M - Total liabilities and shareholders' equity
€6.26M
Company information
- Market capitalization
€3.38M - Employees
5 - Enterprise Value
€350.74M
Company ratios
- Gross margin
-
1.3% - EBITDA margin
-
5.9% - EBIT margin
-
-4.6% - EBT margin
-
1.7% - Net margin
-
1.2% - ROE
-
0.4% - ROA
-
0.4% - Asset turnover
-
36.2% - FCF margin
-
0.0% - FCF yield
0.0% - Efficiency ratio
94.1% - Net sales per employee
-
€452.71K - Net income per employee
-
€5.49K